Today: 15 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble shares rose about 1% to $143.29 Monday afternoon, outpacing the S&P 500’s 0.2% gain as consumer-staples stocks advanced. The move came amid renewed market volatility after news broke of a criminal probe into Fed Chair Jerome Powell. Investors are watching U.S. inflation data and P&G’s Jan. 22 earnings report for further direction.
12 January 2026
··
Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

Thermo Fisher shares fell 1.8% Monday after a regulatory filing showed COO Michel Lagarde and EVP Frederick M. Lowery will depart in the first quarter. The company announced new AI-focused partnerships with TetraScience and Nvidia. Investors await Tuesday’s J.P. Morgan Healthcare Conference and the Jan. 29 earnings report for further signals on demand.
12 January 2026
··
Lockheed Martin stock today: LMT edges up as defense names catch a safety bid

Lockheed Martin stock today: LMT edges up as defense names catch a safety bid

Lockheed Martin shares rose $2.70 to $545.62 Monday as investors moved into defense stocks ahead of Tuesday’s CPI report and amid market volatility. Gains followed threats from the Trump administration to indict Fed Chair Jerome Powell and a proposal to cap credit card interest rates, which pressured financial stocks. Gold and defense shares rallied after Trump floated seizing Greenland. Lockheed reports Q4 earnings Jan. 29.
12 January 2026
···
AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie shares fell 0.6% to $218.81 after announcing a $650 million licensing deal with China’s RemeGen for the experimental cancer drug RC148. RemeGen could receive up to $4.95 billion in milestones and royalties. AbbVie also agreed to buy a device manufacturing plant in Tempe, Arizona, from West Pharmaceutical Services. The S&P health-care sector declined while the broader market rose.
12 January 2026
···
ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

Goldman Sachs initiated coverage of ServiceNow with a Buy rating and a $205 price target Monday, sending shares up 0.2% to around $142 in afternoon trading. The move follows a 3% drop last week. Investors are focused on ServiceNow’s Jan. 28 earnings report for signals on 2026 growth and demand. Stifel recently cut its price target to $200, citing concerns over federal contract trends.
12 January 2026
···
Visa stock slides as Trump’s 10% credit-card rate cap talk hits payments names

Visa stock slides as Trump’s 10% credit-card rate cap talk hits payments names

Visa shares fell 1.6% to $344.25 by early afternoon Monday after President Trump proposed a one-year 10% cap on credit-card interest rates. Mastercard dropped 1.8%, American Express 4.2%. Analysts said such a cap would require Congressional approval, but the announcement increased volatility in card-related stocks. Traders are watching upcoming bank earnings and Tuesday’s CPI for further signals on consumer credit.
12 January 2026
···
IREN stock jumps nearly 9% today as Bernstein tags Nasdaq’s IREN a ‘top AI pick’

IREN stock jumps nearly 9% today as Bernstein tags Nasdaq’s IREN a ‘top AI pick’

IREN Limited shares surged 9% to $50.05 by midday Monday, outpacing other U.S.-listed bitcoin miners. The rally followed Bernstein analyst Gautam Chhugani naming IREN his “top AI pick” and setting a $150,000 bitcoin target for 2026. About 29.2 million shares traded after Friday’s close. Investors are watching Tuesday’s U.S. inflation data for further market direction.
12 January 2026
·
Nvidia stock gains on Eli Lilly $1 billion AI lab plan as traders eye TSMC, earnings

Nvidia stock gains on Eli Lilly $1 billion AI lab plan as traders eye TSMC, earnings

Nvidia and Eli Lilly will invest up to $1 billion in a Bay Area AI drug discovery lab over five years, sending Nvidia shares up 0.8% to $186.37 and Lilly up 0.2% to $1,066.14. AMD, Broadcom, and TSMC also rose as AI-focused stocks lifted the Nasdaq. TSMC reports earnings Jan. 15, with analysts expecting a 27% Q4 profit jump on AI chip demand. Nvidia’s next earnings are due Feb. 25.
12 January 2026
···
Bitcoin price edges higher near $91,000 as Strategy buys $1.25B of BTC; Coinbase stock climbs

Bitcoin price edges higher near $91,000 as Strategy buys $1.25B of BTC; Coinbase stock climbs

Bitcoin rose 0.3% to $91,147 Monday as Coinbase and Marathon Digital shares also gained. Fed Chair Jerome Powell confirmed the Justice Department served the central bank with grand jury subpoenas, sending the dollar lower and gold to a record above $4,600 an ounce. Strategy bought 13,627 bitcoin last week, bringing its holdings to 687,410. Traders await Tuesday’s U.S. CPI report and the Fed’s Jan. 27-28 meeting.
12 January 2026
······
1 … 328 329 330 331 332 … 704

Stock Market Today

  • Dream Industrial REIT Launches Large Buyback, Shaping Investment Outlook
    March 14, 2026, 11:47 PM EDT. Dream Industrial Real Estate Investment Trust (TSX:DIR.UN) announced a normal course issuer bid to repurchase up to 28.27 million units, nearly 10% of its outstanding shares. This move could reduce the equity base, impacting per-unit metrics and capital allocation. The REIT continues its CA$0.70 annualized distribution amidst rising development costs and elevated net debt at 8.2 times EBITDA, posing potential risks if credit conditions tighten. Revenue and earnings are forecasted to grow at 5.9% annually, aiming for CA$611.3 million and CA$350.3 million respectively by 2028. Market estimates value the stock between CA$13.77 and CA$15.46, with a consensus fair value of CA$15.10 signaling a 19% upside. Investors must weigh the benefits of the buyback against leverage concerns and operational performance in industrial logistics real estate.
Go toTop